Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer-Reference-Cited by-同舟云学术

Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer

Published:1993-01 Issue:2 Volume:29 Page:198-202
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bergman Bengt,Brezicka Fred-Thomas,Engström Carl-Peter,Larsson Sture

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference24 articles.

1. Role of biological markers and probes in lung carcinomas;Dorreen;Bull Eur Physiopathol Resp,1986

2. Tumour markers in the clinical management of patients with small cell lung cancer;Hansen;Eur Resp J,1989

3. Analyse comparative des taux sériques de CA-50, CA-125, CA-19.9, ENOLASE et ACE dans les cancers broncho-pulmonaires;Marechal;Rev Pneumol Clin,1987

4. Multiple markers for lung cancer diagnosis: validation of models for localized lung cancer;Gail;J Natl Cancer Inst,1988

5. Diagnostic efficacy of multiple tumor markers in lung cancer;Pohl;J Tumor Marker Oncol,1988

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between serum tumor markers and Anaplastic Lymphoma Kinase mutations in stage IV lung adenocarcinoma in Hubei province, Central China;Journal of Clinical Laboratory Analysis;2019-09-06

2. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer;Cancer Medicine;2019-05-27

3. The level of serum carcinoembryonic antigen is a surrogate marker for the efficacy of EGFR-TKIs but is not an indication of acquired resistance to EGFR-TKIs in NSCLC patients with EGFR mutationsm;Biomedical Reports;2017-05-19

4. Serum Carcinoembryonic Antigen Levels before Initial Treatment are Associated with EGFR Mutations and EML4-ALK Fusion Gene in Lung Adenocarcinoma Patients;Asian Pacific Journal of Cancer Prevention;2014-05-15

5. Cytokeratin 19 Fragment Predicts the Efficacy of Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor in Non–Small-Cell Lung Cancer Harboring EGFR Mutation;Journal of Thoracic Oncology;2013-07